91 related articles for article (PubMed ID: 25849345)
1. Direct evaluation of molecular States of piroxicam/poloxamer nanosuspension by suspended-state NMR and Raman spectroscopies.
Hasegawa Y; Higashi K; Yamamoto K; Moribe K
Mol Pharm; 2015 May; 12(5):1564-72. PubMed ID: 25849345
[TBL] [Abstract][Full Text] [Related]
2. Nano-scale and molecular-level understanding of wet-milled indomethacin/poloxamer 407 nanosuspension with TEM, suspended-state NMR, and Raman measurements.
Kuroiwa Y; Higashi K; Ueda K; Yamamoto K; Moribe K
Int J Pharm; 2018 Feb; 537(1-2):30-39. PubMed ID: 29246438
[TBL] [Abstract][Full Text] [Related]
3. Interaction of urea with pluronic block copolymers by 1H NMR spectroscopy.
Ma JH; Guo C; Tang YL; Chen L; Bahadur P; Liu HZ
J Phys Chem B; 2007 May; 111(19):5155-61. PubMed ID: 17439172
[TBL] [Abstract][Full Text] [Related]
4. Combination of NMR Methods To Reveal the Interfacial Structure of a Pharmaceutical Nanocrystal and Nanococrystal in the Suspended State.
Kojima T; Karashima M; Yamamoto K; Ikeda Y
Mol Pharm; 2018 Sep; 15(9):3901-3908. PubMed ID: 30059624
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of polypseudorotaxanes based on block-selected inclusion complexation between poly(propylene oxide)-poly(ethylene oxide)-poly(propylene oxide) triblock copolymers and alpha-cyclodextrin.
Li J; Ni X; Zhou Z; Leong KW
J Am Chem Soc; 2003 Feb; 125(7):1788-95. PubMed ID: 12580604
[TBL] [Abstract][Full Text] [Related]
6. Transition from Amorphous Cyclosporin A Nanoparticles to Size-Reduced Stable Nanocrystals in a Poloxamer 407 Solution.
Chen Z; Higashi K; Ueda K; Moribe K
Mol Pharm; 2022 Jan; 19(1):188-199. PubMed ID: 34843257
[TBL] [Abstract][Full Text] [Related]
7. Raman and solid state 13C-NMR investigation of the structure of the 1 : 1 amorphous piroxicam : beta-cyclodextrin inclusion compound.
Redenti E; Zanol M; Ventura P; Fronza G; Comotti A; Taddei P; Bertoluzza A
Biospectroscopy; 1999; 5(4):243-51. PubMed ID: 10478955
[TBL] [Abstract][Full Text] [Related]
8. Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes.
Sheth AR; Lubach JW; Munson EJ; Muller FX; Grant DJ
J Am Chem Soc; 2005 May; 127(18):6641-51. PubMed ID: 15869285
[TBL] [Abstract][Full Text] [Related]
9. Temperature-dependent aggregation and disaggregation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block copolymer in aqueous solution.
Liang X; Guo C; Ma J; Wang J; Chen S; Liu H
J Phys Chem B; 2007 Nov; 111(46):13217-20. PubMed ID: 17973418
[TBL] [Abstract][Full Text] [Related]
10. Nature of interactions between PEO-PPO-PEO triblock copolymers and lipid membranes: (II) role of hydration dynamics revealed by dynamic nuclear polarization.
Cheng CY; Wang JY; Kausik R; Lee KY; Han S
Biomacromolecules; 2012 Sep; 13(9):2624-33. PubMed ID: 22808941
[TBL] [Abstract][Full Text] [Related]
11. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
[TBL] [Abstract][Full Text] [Related]
12. Crystallization of Probucol in Nanoparticles Revealed by AFM Analysis in Aqueous Solution.
Egami K; Higashi K; Yamamoto K; Moribe K
Mol Pharm; 2015 Aug; 12(8):2972-80. PubMed ID: 26106951
[TBL] [Abstract][Full Text] [Related]
13. Solid-state NMR studies of the crystalline and amorphous domains within PEO and PEO: LiTf systems.
Wickham JR; Mason RN; Rice CV
Solid State Nucl Magn Reson; 2007 Jul; 31(4):184-92. PubMed ID: 17587555
[TBL] [Abstract][Full Text] [Related]
14. Effect of pharmaceutically acceptable glycols on the stability of the liquid crystalline gels formed by Poloxamer 407 in water.
Ivanova R; Lindman B; Alexandridis P
J Colloid Interface Sci; 2002 Aug; 252(1):226-35. PubMed ID: 16290783
[TBL] [Abstract][Full Text] [Related]
15. Pluronic block copolymer-mediated interactions of organic compounds with noble metal nanoparticles for SERS analysis.
Abdullin TI; Bondar OV; Shtyrlin YG; Kahraman M; Culha M
Langmuir; 2010 Apr; 26(7):5153-9. PubMed ID: 20350012
[TBL] [Abstract][Full Text] [Related]
16. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.
George M; Ghosh I
Eur J Pharm Sci; 2013 Jan; 48(1-2):142-52. PubMed ID: 23085547
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling.
Naelapää K; Boetker JP; Veski P; Rantanen J; Rades T; Kogermann K
Int J Pharm; 2012 Jun; 429(1-2):69-77. PubMed ID: 22433471
[TBL] [Abstract][Full Text] [Related]
18. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
[TBL] [Abstract][Full Text] [Related]
19. Effect of wet milling process on the solid state of indomethacin and simvastatin.
Sharma P; Denny WA; Garg S
Int J Pharm; 2009 Oct; 380(1-2):40-8. PubMed ID: 19576976
[TBL] [Abstract][Full Text] [Related]
20. Effect of particle size on skin permeation and retention of piroxicam in aqueous suspension.
Moribe K; Shibata M; Furuishi T; Higashi K; Tomono K; Yamamoto K
Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1096-9. PubMed ID: 20686267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
